Table 2. Mean± SD of serum malondialdehyde (MDA), Alanine transaminase (ALT) and Aspartate transaminase (AST) in control and treatment groups (received 0.2, 2 and 20% peracetic acid daily for 4 weeks).
| Group | MDA (nmol/ml) | ALT (IU/L) | AST (IU/L) |
|---|---|---|---|
| Control | 2.62±0.40 | 35.43±7.27 | 33.75±2.62 |
| Treatment Group I | 2.67±0.09 | 34.50±1.29 | 32.50±2.08 |
| Treatment Group II | 5.03±0.46* | 23.75±1.50* | 27.25±1.50* |
| Treatment Group III | ----- | ----- | ----- |
Values are means ± SD. Calculated from n=6 in each group.
* p<0.05 compared to control and Treatment Group I (ANOVA).
(I): Treatment Group received 0.2% PAA daily for 4 weeks.
(II) Treatment Group received 2% PAA daily for 4 weeks.
(III) Treatment Group received 20% PAA daily for 4 weeks (no sampling).